Search
for
Sort by
Research 301–330 of 1000+
- CD34 <sup>+</sup> cell–derived fibroblast-macrophage cross-talk drives limb ischemia recovery through the OSM-ANGPTL signaling axis
- LncRNA-PCAT1 maintains characteristics of dermal papilla cells and promotes hair follicle regeneration by regulating miR-329/Wnt10b axis
- The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience
- Biologics in the management of childhood atopic dermatitis
- JAK1 gain-of-function variant causes alopecia areata, atopic dermatitis, and autoimmune thyroid disease
- 802 Molecular effect of brepocitinib in hidradenitis suppurativa (HS)
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- A Case of Vitiligo Combined with Systemic Lupus Erythematosus Treated with Tofacitinib
- Immune therapies for alopecia areata: evidence and new perspectives
- Citrullination at the Inflammatory Skin Barrier
- Delayed granulomatous eruption of the nose associated with ruxolitinib
- 477 How Cannabidiol Supports Hair Growth: From Epigenetics to the Scalp Microbiome
- Review of efficacy of baricitinib in the treatment of alopecia areata
- The role of Janus kinase inhibitors in the treatment of alopecia areata: A systematic review
- Time-course RNA-seq analysis reveals stage-specific and melatonin-triggered gene expression patterns during the hair follicle growth cycle in Capra hircus
- A review of Janus kinase inhibitor use in scarring alopecia
- Janus kinase inhibitors for alopecia areata: A narrative review
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- Systemic Inflammation Marker Alterations in Severe Alopecia Areata Patients Treated with Janus Kinase Inhibitors
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- A systematic review of tumor necrosis factor-α blockers, anti-interleukins, and small molecule inhibitors for dissecting cellulitis of the scalp treatment
- Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata
- Is female-pattern hair loss an autoimmune-like disorder? Unveiling the “silent” inflammation
- Pathomechanisms of immune-mediated alopecia
- Baricitinib: A Review in Severe Alopecia Areata
- Exploring novel management options for alopecia areata
- Quercetin Promotes Production of Secondary Hair Follicle Stem Cells in Cashmere Goat: A Mechanistic Study
- Perspectives of Chinese Adult Patients with Alopecia Areata on Janus Kinase Inhibitors Therapy: A Qualitative Analysis Based on Social Media Platforms